¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
ºñÀÚ¼º ÈÙü¾î ½ÃÀå ¼ºÀå ¹× µ¿Çâ:
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é, ºñÀÚ¼º ÈÙü¾î ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 8,870¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö 6.9%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â ³ëÀÎ Àα¸ÀÇ Áõ°¡, »ý¸®Àû ¹× ½Å°æÇÐÀû ÁúȯÀÇ ºÎ´ã Áõ°¡, ¼±Áø±¹°ú °³¹ßµµ»ó±¹ÀÇ Ã·´Ü ÀÇ·á ¿µ»ó ±â¼ú äÅÃÀÌ ÀÖ½À´Ï´Ù. ´Ù¹ß¼º °æÈÁõ(MS), ÆÄŲ½¼º´(PD), ±ÙÀ§Ã༺ Ãø»è°æÈÁõ(ALS), ô¼ö¼Õ»ó, ³úÁ¹Áß µî Áúº´Àº À̵¿ Àå¾Ö¸¦ À¯¹ßÇϰí ÈÙü¾îÀÇ Çʿ伺À» Áõ°¡½Ãŵ´Ï´Ù. 2022³â 5¿ù ¹Ì±¹ ´Ù¹ß¼º °æÈÁõ ÇùȸÀÇ ±â»ç¿¡ µû¸£¸é, ¹Ì±¹¿¡¼´Â ¾à 100¸¸ ¸íÀÌ ´Ù¹ß¼º °æÈÁõ¿¡ ½Ã´Þ¸®°í ÀÖ½À´Ï´Ù.
³ëÀÎ Àα¸ÀÇ Áõ°¡´Â ºñÀÚ¼º ÈÙü¾î¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, OECD°¡ 2021³â ¹ßÇ¥ÇÑ º¸°í¼¿¡ µû¸£¸é ¾Æ½Ã¾Æ ÁßÀú¼Òµæ ±¹°¡ÀÇ Æò±Õ ¼ö¸íÀº 2000³â ÀÌÈÄ 6³â, °í¼Òµæ ±¹°¡´Â 4³âÀÌ ´Ã¾î³µ´Ù°í ÇÕ´Ï´Ù. ¸¶Âù°¡Áö·Î ¼¼°èº¸°Ç±â±¸(WHO)´Â 2050³â±îÁö °¢±¹ Àüü¿¡¼ ¾à 21¾ï ¸íÀÌ 60¼¼ ÀÌ»óÀÌ µÉ °ÍÀ¸·Î ÃßÁ¤Çϰí ÀÖ½À´Ï´Ù.
ÀÚ±â°ø¸í¿µ»óÀåÄ¡(MRI)¿Í °°Àº °ËÁø ¼ö´ÜÀÇ Ã¤ÅÃÀÌ °¢±¹¿¡¼ ÁøÇàµÇ°í ÀÖ´Â °ÍÀº ÈÙü¾î ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÇコÄÉ¾î ºÐ¾ßÀÇ ¹Î°ü ÆÄÆ®³Ê½ÊÀº ½ÃÀå Âü¿©Àڵ鿡°Ô ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ¿µ±¹ Á¤ºÎ´Â 2023³â 8¿ù, 2025³â±îÁö Àü±¹¿¡ 160°³ÀÇ Áø´Ü ¼¾Å͸¦ ¼³¸³ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ÇÁ·ÎÁ§Æ® ºñ¿ëÀº 29¾ï 3,000¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù.
ºñÀÚ¼º ÈÙü¾î ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- ºÏ¹Ì´Â 2023³â 34.86%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÷´Ü ÀÇ·á ±â¼úÀÇ Á¸Àç, ¿ì¼öÇÑ ÀÇ·á »óȯ Á¤Ã¥, Áúº´¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡°¡ ±× ¿äÀÎÀÔ´Ï´Ù.
- 2023³â ¸ÅÃâ Á¡À¯À²Àº 47.75%·Î, ȯÀÚ Ã¼Áß 100kg-150kg Ä«Å×°í¸®°¡ ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù.
- ÀÚÀå °µµ¸¦ ±âÁØÀ¸·Î 2023³â 3T±îÁöÀÇ ºÎ¹®ÀÌ 78.79%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¿ìÀ§¸¦ Á¡Çß½À´Ï´Ù.
- º´¿ø ÃÖÁ¾ ¿ëµµ ºÎ¹®Àº 2023³â 51.49%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¿ìÀ§¸¦ Á¡Çß½À´Ï´Ù. ÀÌ ¾ÐµµÀûÀÎ Á¡À¯À²Àº ´Ù¾çÇÑ È¯ÀÚ±ºÀ» ¼ö¿ëÇÏ´Â º´¿øµéÀÌ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ºñÀÚ¼º ÈÙü¾î ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- ½ÃÀå µ¿Çâ°ú Àü¸Á
- ½ÃÀå ¿ªÇÐ
- »ç¾÷ ȯ°æ ºÐ¼®
Á¦4Àå ºñÀÚ¼º ÈÙü¾î ½ÃÀå : ȯÀÚ Ã¼Áß ºñÁö´Ï½º ºÐ¼®
- ºñÀÚ¼º ÈÙü¾î ½ÃÀå : ȯÀÚ Ã¼Áß º¯µ¿°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â°ú 2030³â
- 100kg ¹Ì¸¸
- 100kg-150kg
- 150kg ÀÌ»ó
Á¦5Àå ºñÀÚ¼º ÈÙü¾î ½ÃÀå : ÀÚÀå °µµ ºñÁö´Ï½º ºÐ¼®
- ºñÀÚ¼º ÈÙü¾î ½ÃÀå : ÀÚÀå °µµ º¯µ¿°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â°ú 2030³â
- 3T ¹Ì¸¸
- 7T ¹Ì¸¸
Á¦6Àå ºñÀÚ¼º ÈÙü¾î ½ÃÀå : ÃÖÁ¾ ¿ëµµ ºñÁö´Ï½º ºÐ¼®
- ºñÀÚ¼º ÈÙü¾î ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â°ú 2030³â
- º´¿ø
- ¿Ü·¡ ½Ã¼³
Á¦7Àå ºñÀÚ¼º ÈÙü¾î ½ÃÀå : Áö¿ª ºñÁö´Ï½º ºÐ¼®
- Áö¿ª ½ÃÀå ÇöȲ
- ±¹°¡º° ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦8Àå °æÀï »óȲ
- ±â¾÷ ºÐ·ù
- Àü·« ¸ÅÇÎ
- ±â¾÷ °³¿ä¡¤¸®½ºÆ®
- GF Health Products, Inc.
- Magmedix Inc.
- MRIequip.com
- Newmatic Medical
- AliMed
- Innovative Products Unlimited, Inc.
- Nanning Hhao Technology Co., Ltd
- Matsunaga
- Hebei Webian Medical Instrument Co., Ltd
- Jiangsu Rooe Medical Technology Co., Ltd
ksm 24.01.18
Non-magnetic Wheelchair Market Growth & Trends:
The global non-magnetic wheelchair market size is expected to reach USD 88.7 million by 2030 and display a CAGR of 6.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the growing geriatric population, increasing burden of physiological and neurological diseases, and adoption of advanced healthcare imaging technologies in developed and developing countries. Diseases such as multiple sclerosis (MS), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), spinal cord injuries, and stroke lead to mobility impairments, which augments the need for wheelchairs. According to an article by the Multiple Sclerosis Association of America in May 2022, nearly 1 million people in the U.S. suffer from MS.
The growing geriatric population is expected to drive the demand for non-magnetic wheelchairs. According to OECD's report in 2021, the life expectancy in lower- and middle-income Asian countries has increased by six years from 2000, while upper-middle-income countries have recorded a growth of four years in life expectancy. Similarly, the WHO estimates that by 2050, nearly 2.1 billion people across countries will be aged over 60.
Growing adoption of screening modalities such as magnetic resonance imaging (MRI) across countries is expected to drive demand for wheelchairs. In addition, public-private partnership in the healthcare sector is expected to create favorable opportunities for the market players. For instance, in August 2023, the UK government aims to establish 160 diagnostic centers nationwide by 2025. The project cost is estimated at USD 2.93 billion.
Non-magnetic Wheelchair Market Report Highlights:
- North America dominated the market with a revenue share of 34.86% in 2023, attributed to the presence of advanced healthcare technologies, superior healthcare reimbursement policies, and a growing geriatric population susceptible to diseases
- With 47.75% of revenue share in 2023, the 100 kg to 150 kg patient weight category led the market
- Based on field strength, up to 3T segment dominated with a revenue share of 78.79% in 2023
- Hospitals end-use segment dominated with a revenue share of 51.49% in 2023. The dominant share is attributed to hospitals as they cater to a diverse patient population
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.5.1. Volume Price Analysis
- 1.5.1.1. Approach 1: Volume Price Analysis
- 1.6. Data Validation & Publishing
- 1.7. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Non-Magnetic Wheelchair Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.1.1. Increasing geriatric population
- 3.3.1.2. Growing prevalence of physiological and neurological diseases
- 3.3.1.3. Increasing installations of imaging modalities such as magnetic resonance imaging (MRI).
- 3.3.2. Market restraint analysis
- 3.3.2.1. Stringent regulatory rule for providers
- 3.3.2.2. High-cost variability across regions and limited manufacturer presence
- 3.4. Business Environment Analysis
- 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
- 3.4.2. Porter's Five Forces Analysis
- 3.4.3. COVID-19 Impact Analysis
Chapter 4. Non-Magnetic Wheelchair Market: Patient Weight Business Analysis
- 4.1. Non-Magnetic Wheelchair Market: Patient Weight Movement & Market Share Analysis, 2023 & 2030
- 4.2. Below 100 kg
- 4.2.1. Below 100 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3. 100 kg to 150 kg
- 4.3.1. 100 kg to 150 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Above 150 kg
- 4.4.1. Above 150 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Non-Magnetic Wheelchair Market: Magnetic Field Strength Business Analysis
- 5.1. Non-Magnetic Wheelchair Market: Magnetic Field Strength Movement & Market Share Analysis, 2023 & 2030
- 5.2. Up to 3T
- 5.2.1. Up to 3T Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3. Up to 7T
- 5.3.1. Up to 7T Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Non-Magnetic Wheelchair Market: End-use Business Analysis
- 6.1. Non-Magnetic Wheelchair Market: End-use Movement & Market Share Analysis, 2023 & 2030
- 6.2. Hospitals
- 6.2.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3. Outpatient Facilities
- 6.3.1. Outpatient Facilities Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Non-Magnetic Wheelchair Market: Regional Business Analysis
- 7.1. Regional Market Snapshot
- 7.2. Market Share Analysis by Country, 2023
- 7.2.1. North America
- 7.2.2. Europe
- 7.2.3. Asia Pacific
- 7.2.4. Latin America
- 7.2.5. MEA
- 7.3. North America
- 7.3.1. North America Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. U.S. Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.3.2.2. Key Country Dynamics
- 7.3.2.3. Competitive Scenario
- 7.3.2.4. Regulatory Framework
- 7.3.3. Canada
- 7.3.3.1. Canada Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.3.3.2. Key Country Dynamics
- 7.3.3.3. Competitive Scenario
- 7.3.3.4. Regulatory Framework
- 7.4. Europe
- 7.4.1. Europe Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Germany Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.2.2. Key Country Dynamics
- 7.4.2.3. Competitive Scenario
- 7.4.2.4. Regulatory Framework
- 7.4.3. UK
- 7.4.3.1. UK Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.3.2. Key Country Dynamics
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Regulatory Framework
- 7.4.4. France
- 7.4.4.1. France Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.4.2. Key Country Dynamics
- 7.4.4.3. Competitive Scenario
- 7.4.4.4. Regulatory Framework
- 7.4.5. Italy
- 7.4.5.1. Italy Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.5.2. Key Country Dynamics
- 7.4.5.3. Competitive Scenario
- 7.4.5.4. Regulatory Framework
- 7.4.6. Spain
- 7.4.6.1. Spain Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.6.2. Key Country Dynamics
- 7.4.6.3. Competitive Scenario
- 7.4.6.4. Regulatory Framework
- 7.4.7. Denmark
- 7.4.7.1. Denmark Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.7.2. Key Country Dynamics
- 7.4.7.3. Competitive Scenario
- 7.4.7.4. Regulatory Framework
- 7.4.8. Sweden
- 7.4.8.1. Sweden Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.8.2. Key Country Dynamics
- 7.4.8.3. Competitive Scenario
- 7.4.8.4. Regulatory Framework
- 7.4.9. Norway
- 7.4.9.1. Norway Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.4.9.2. Key Country Dynamics
- 7.4.9.3. Competitive Scenario
- 7.4.9.4. Regulatory Framework
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Japan Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.5.2.2. Key Country Dynamics
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. Regulatory Framework
- 7.5.3. China
- 7.5.3.1. China Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.5.3.2. Key Country Dynamics
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Regulatory Framework
- 7.5.4. India
- 7.5.4.1. India Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.5.4.2. Key Country Dynamics
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Regulatory Framework
- 7.5.5. South Korea
- 7.5.5.1. South Korea Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.5.5.2. Key Country Dynamics
- 7.5.5.3. Competitive Scenario
- 7.5.5.4. Regulatory Framework
- 7.5.6. Australia
- 7.5.6.1. Australia Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.5.6.2. Key Country Dynamics
- 7.5.6.3. Competitive Scenario
- 7.5.6.4. Regulatory Framework
- 7.5.7. Thailand
- 7.5.7.1. Thailand Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.5.7.2. Key Country Dynamics
- 7.5.7.3. Competitive Scenario
- 7.5.7.4. Regulatory Framework
- 7.6. Latin America
- 7.6.1. Latin America Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Brazil Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.6.2.2. Key Country Dynamics
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. Regulatory Framework
- 7.6.3. Mexico
- 7.6.3.1. Mexico Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.6.3.2. Key Country Dynamics
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Regulatory Framework
- 7.6.4. Argentina
- 7.6.4.1. Argentina Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.6.4.2. Key Country Dynamics
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. Regulatory Framework
- 7.7. MEA
- 7.7.1. MEA Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. South Africa Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.7.2.2. Key Country Dynamics
- 7.7.2.3. Competitive Scenario
- 7.7.2.4. Regulatory Framework
- 7.7.3. Saudi Arabia
- 7.7.3.1. Saudi Arabia Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.7.3.2. Key Country Dynamics
- 7.7.3.3. Competitive Scenario
- 7.7.3.4. Regulatory Framework
- 7.7.4. UAE
- 7.7.4.1. UAE Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.7.4.2. Key Country Dynamics
- 7.7.4.3. Competitive Scenario
- 7.7.4.4. Regulatory Framework
- 7.7.5. Kuwait
- 7.7.5.1. Kuwait Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
- 7.7.5.2. Key Country Dynamics
- 7.7.5.3. Competitive Scenario
- 7.7.5.4. Regulatory Framework
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Profiles/Listing
- 8.3.1. GF Health Products, Inc.
- 8.3.1.1. Overview
- 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.1.3. Product Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Magmedix Inc.
- 8.3.2.1. Overview
- 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.2.3. Product Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. MRIequip.com
- 8.3.3.1. Overview
- 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.3.3. Product Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. Newmatic Medical
- 8.3.4.1. Overview
- 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. AliMed
- 8.3.5.1. Overview
- 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. Innovative Products Unlimited, Inc.
- 8.3.6.1. Overview
- 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. Nanning Hhao Technology Co., Ltd
- 8.3.7.1. Overview
- 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. Matsunaga
- 8.3.8.1. Overview
- 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. Hebei Webian Medical Instrument Co., Ltd
- 8.3.9.1. Overview
- 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. Jiangsu Rooe Medical Technology Co., Ltd
- 8.3.10.1. Overview
- 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.10.3. Product Benchmarking
- 8.3.10.4. Strategic Initiatives